PDCD1 and colorectal carcinoma: Strasser et al. showed that the TME of CRC consists of both pro- and anti-inflammatory immune cells which promotes progression of the CRC and might explain why inhibition of PD-1/PD-L1 is not that effective in CRC (Strasser et al., 2019).